CMRA
Price:
$0.0222
Market Cap:
$682.38K
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2020-12-21
Stock Exchange
NASDAQ
Ticker
CMRA
According to Comera Life Sciences Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.90. This represents a change of 33.81% compared to the average of 0.67 of the last 4 quarters.
The mean historical Current Ratio of Comera Life Sciences Holdings, Inc. over the last ten years is 2.81. The current 0.90 Current Ratio has changed 3.09% with respect to the historical average. Over the past ten years (40 quarters), CMRA's Current Ratio was at its highest in in the September 2021 quarter at 402.07. The Current Ratio was at its lowest in in the March 2021 quarter at 0.
Average
2.81
Median
1.33
Minimum
0.61
Maximum
6.49
Discovering the peaks and valleys of Comera Life Sciences Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 387.85%
Maximum Annual Current Ratio = 6.49
Minimum Annual Increase = -90.67%
Minimum Annual Current Ratio = 0.61
Year | Current Ratio | Change |
---|---|---|
2022 | 0.61 | -90.67% |
2021 | 6.49 | 387.85% |
The current Current Ratio of Comera Life Sciences Holdings, Inc. (CMRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.81
5-year avg
2.81
10-year avg
2.81
Comera Life Sciences Holdings, Inc.’s Current Ratio is less than SAB Biotherapeutics, Inc. (5.24), less than Processa Pharmaceuticals, Inc. (4.82), less than Fresh Tracks Therapeutics, Inc. (6.98), less than Third Harmonic Bio, Inc. (41.13), less than Indaptus Therapeutics, Inc. (3.88), less than Rezolute, Inc. (11.82), less than Tempest Therapeutics, Inc. (2.17), less than Forte Biosciences, Inc. (2.82), less than Genelux Corporation (6.01), less than Dyadic International, Inc. (5.39), less than Cingulate Inc. (1.20), less than Monopar Therapeutics Inc. (6.59), less than Shattuck Labs, Inc. (7.62), less than C4 Therapeutics, Inc. (5.09), less than Eliem Therapeutics, Inc. (60.41), less than Prelude Therapeutics Incorporated (7.83), less than Monte Rosa Therapeutics, Inc. (6.56), less than Virax Biolabs Group Limited (25.94), greater than Blue Water Vaccines, Inc. (0.54), less than Revelation Biosciences, Inc. (1.10), less than Hillstream BioPharma, Inc. (2.25), less than Kiora Pharmaceuticals, Inc. (19.22),
Company | Current Ratio | Market cap |
---|---|---|
5.24 | $25.75M | |
4.82 | $4.56M | |
6.98 | $4.45M | |
41.13 | $526.25M | |
3.88 | $15.30M | |
11.82 | $285.09M | |
2.17 | $34.03M | |
2.82 | $10.70M | |
6.01 | $87.37M | |
5.39 | $37.14M | |
1.20 | $11.05M | |
6.59 | $15.10M | |
7.62 | $175.64M | |
5.09 | $438.56M | |
60.41 | $552.58M | |
7.83 | $143.06M | |
6.56 | $344.30M | |
25.94 | $12.42M | |
0.54 | $3.41M | |
1.10 | $1.50M | |
2.25 | $4.17M | |
19.22 | $10.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Comera Life Sciences Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Comera Life Sciences Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Comera Life Sciences Holdings, Inc.'s Current Ratio?
How is the Current Ratio calculated for Comera Life Sciences Holdings, Inc. (CMRA)?
What is the highest Current Ratio for Comera Life Sciences Holdings, Inc. (CMRA)?
What is the 3-year average Current Ratio for Comera Life Sciences Holdings, Inc. (CMRA)?
What is the 5-year average Current Ratio for Comera Life Sciences Holdings, Inc. (CMRA)?
How does the current Current Ratio for Comera Life Sciences Holdings, Inc. (CMRA) compare to its historical average?